High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$1.8M
$1,785,488
Total Sells (Filtered)
$134K
$134,358
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TLSI |
TriSalus Life Sciences, Inc.
|
CEO
Sell to Cover
|
2026-03-17 | $61,384 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Devlin Jodi
• Officer • Chief of Clinical Operations
Sell to Cover
2026-03-16
$1,125
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief of Clinical Operations
Sell to Cover
|
2026-03-16 | $1,125 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Stevens Jennifer
• Officer • Chief Regulatory Officer
Sell to Cover
2026-03-16
$3,189
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief Regulatory Officer
Sell to Cover
|
2026-03-16 | $3,189 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Marshak Richard
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-16
$1,726
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-16 | $1,726 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Cox Bryan F.
• Officer • Chief of Research
Sell to Cover
2026-03-16
$2,385
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief of Research
Sell to Cover
|
2026-03-16 | $2,385 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Devlin Jodi
• Officer • Chief of Clinical Operations
Sell to Cover
2026-03-12
$7,247
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief of Clinical Operations
Sell to Cover
|
2026-03-12 | $7,247 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Cox Bryan F.
• Officer • Chief of Research
Sell to Cover
2026-03-12
$6,000
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief of Research
Sell to Cover
|
2026-03-12 | $6,000 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Stevens Jennifer
• Officer • Chief Regulatory Officer
Sell to Cover
2026-03-12
$6,348
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief Regulatory Officer
Sell to Cover
|
2026-03-12 | $6,348 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Marshak Richard
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-12
$6,499
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-12 | $6,499 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Cox Bryan F.
• Officer • Chief of Research
Sell to Cover
2026-03-11
$4,700
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief of Research
Sell to Cover
|
2026-03-11 | $4,700 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Devlin Jodi
• Officer • Chief of Clinical Operations
Sell to Cover
2026-03-11
$4,799
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief of Clinical Operations
Sell to Cover
|
2026-03-11 | $4,799 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Marshak Richard
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-11
$5,984
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-11 | $5,984 | S | Form 4 |
| TLSI |
TriSalus Life Sciences, Inc.
|
CEO
Sell to Cover
|
2026-03-11 | $17,999 | S | Form 4 |
|
TLSI
S
TriSalus Life Sciences, Inc.
Stevens Jennifer
• Officer • Chief Regulatory Officer
Sell to Cover
2026-03-11
$4,973
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Officer • Chief Regulatory Officer
Sell to Cover
|
2026-03-11 | $4,973 | S | Form 4 |
| TLSI |
TriSalus Life Sciences, Inc.
|
Director
Discretionary Buy
|
2026-02-23 | $124,997 | P | Form 4 |
|
TLSI
P
TriSalus Life Sciences, Inc.
Stansky Michael P
• Director
Discretionary BuyΔOwn +44.9%
2026-02-23
$999,990
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Director
Discretionary BuyΔOwn +44.9%
|
2026-02-23 | $999,990 | P | Form 4 |
| TLSI |
TriSalus Life Sciences, Inc.
|
CEO
Discretionary Buy
|
2026-02-23 | $124,997 | P | Form 4 |
|
TLSI
P
TriSalus Life Sciences, Inc.
Stansky Michael P
• Director
Discretionary BuyΔOwn +142.1%
2026-02-23
$480,512
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Director
Discretionary BuyΔOwn +142.1%
|
2026-02-23 | $480,512 | P | Form 4 |
| TLSI |
TriSalus Life Sciences, Inc.
|
Director
Discretionary Buy
|
2026-02-23 | $40,000 | P | Form 4 |
| TLSI |
TriSalus Life Sciences, Inc.
|
CFO
Discretionary Buy
|
2026-02-23 | $14,994 | P | Form 4 |